vs
Ceribell, Inc.（CBLL）与康美（CNMD）财务数据对比。点击上方公司名可切换其他公司
康美的季度营收约是Ceribell, Inc.的15.1倍（$373.2M vs $24.8M）。康美自由现金流更多（$41.2M vs $-11.0M）
Ceribell, Inc.是一家专注于神经诊断领域的医疗科技企业，主打便携式快速脑电图检测设备，可为急症、重症护理场景提供便捷的癫痫发作监测解决方案，核心市场覆盖北美地区，目前正逐步推进全球化业务布局。
康美公司是一家上市的美国医疗设备制造商，主营骨科、腹腔镜、普通外科相关医疗器械以及各类患者护理产品，总部现位于佛罗里达州拉戈，2022年7月前设于纽约州尤蒂卡。该品牌秉持以人为本的文化，以助力医疗合作方及其服务的患者为核心使命，在美国和墨西哥都设有生产基地。
CBLL vs CNMD — 直观对比
营收规模更大
CNMD
是对方的15.1倍
$24.8M
自由现金流更多
CNMD
多$52.2M
$-11.0M
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $24.8M | $373.2M |
| 净利润 | $-13.5M | — |
| 毛利率 | 87.3% | 58.5% |
| 营业利润率 | -58.9% | 9.8% |
| 净利率 | -54.6% | — |
| 营收同比 | — | 7.9% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $-0.35 | $0.54 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CBLLCNMD
| Q4 25 | $24.8M | $373.2M | ||
| Q3 25 | $22.6M | $337.9M | ||
| Q2 25 | $21.2M | $342.3M | ||
| Q1 25 | $20.5M | $321.3M | ||
| Q4 24 | — | $345.9M | ||
| Q3 24 | $17.2M | $316.7M | ||
| Q2 24 | — | $332.1M | ||
| Q1 24 | — | $312.3M |
净利润CBLLCNMD
| Q4 25 | $-13.5M | — | ||
| Q3 25 | $-13.5M | $2.9M | ||
| Q2 25 | $-13.6M | $21.4M | ||
| Q1 25 | $-12.8M | $6.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-10.4M | $49.0M | ||
| Q2 24 | — | $30.0M | ||
| Q1 24 | — | $19.7M |
毛利率CBLLCNMD
| Q4 25 | 87.3% | 58.5% | ||
| Q3 25 | 88.3% | 49.2% | ||
| Q2 25 | 88.1% | 55.0% | ||
| Q1 25 | 87.9% | 55.3% | ||
| Q4 24 | — | 57.3% | ||
| Q3 24 | 87.3% | 56.5% | ||
| Q2 24 | — | 55.3% | ||
| Q1 24 | — | 55.1% |
营业利润率CBLLCNMD
| Q4 25 | -58.9% | 9.8% | ||
| Q3 25 | -64.8% | 3.5% | ||
| Q2 25 | -70.5% | 11.1% | ||
| Q1 25 | -69.3% | 5.0% | ||
| Q4 24 | — | 15.2% | ||
| Q3 24 | -57.8% | 20.7% | ||
| Q2 24 | — | 14.2% | ||
| Q1 24 | — | 11.2% |
净利率CBLLCNMD
| Q4 25 | -54.6% | — | ||
| Q3 25 | -59.6% | 0.8% | ||
| Q2 25 | -64.4% | 6.3% | ||
| Q1 25 | -62.4% | 1.9% | ||
| Q4 24 | — | — | ||
| Q3 24 | -60.6% | 15.5% | ||
| Q2 24 | — | 9.0% | ||
| Q1 24 | — | 6.3% |
每股收益（稀释后）CBLLCNMD
| Q4 25 | $-0.35 | $0.54 | ||
| Q3 25 | $-0.37 | $0.09 | ||
| Q2 25 | $-0.38 | $0.69 | ||
| Q1 25 | $-0.36 | $0.19 | ||
| Q4 24 | — | $1.09 | ||
| Q3 24 | $-1.85 | $1.57 | ||
| Q2 24 | — | $0.96 | ||
| Q1 24 | — | $0.63 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $159.3M | — |
| 总债务越低越好 | — | $834.2M |
| 股东权益账面价值 | $155.3M | $1.0B |
| 总资产 | $195.8M | $2.3B |
| 负债/权益比越低杠杆越低 | — | 0.81× |
8季度趋势，按日历期对齐
现金及短期投资CBLLCNMD
| Q4 25 | $159.3M | — | ||
| Q3 25 | $168.5M | — | ||
| Q2 25 | $177.4M | — | ||
| Q1 25 | $182.7M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $14.1M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
总债务CBLLCNMD
| Q4 25 | — | $834.2M | ||
| Q3 25 | — | $853.0M | ||
| Q2 25 | — | $881.1M | ||
| Q1 25 | — | $891.4M | ||
| Q4 24 | — | $905.1M | ||
| Q3 24 | — | $940.1M | ||
| Q2 24 | — | $965.2M | ||
| Q1 24 | — | $990.1M |
股东权益CBLLCNMD
| Q4 25 | $155.3M | $1.0B | ||
| Q3 25 | $164.1M | $1.0B | ||
| Q2 25 | $172.2M | $1.0B | ||
| Q1 25 | $180.9M | $977.6M | ||
| Q4 24 | — | $962.7M | ||
| Q3 24 | $-136.0M | $932.9M | ||
| Q2 24 | — | $881.8M | ||
| Q1 24 | — | $854.7M |
总资产CBLLCNMD
| Q4 25 | $195.8M | $2.3B | ||
| Q3 25 | $199.5M | $2.3B | ||
| Q2 25 | $207.7M | $2.3B | ||
| Q1 25 | $213.5M | $2.3B | ||
| Q4 24 | — | $2.3B | ||
| Q3 24 | $47.1M | $2.3B | ||
| Q2 24 | — | $2.3B | ||
| Q1 24 | — | $2.3B |
负债/权益比CBLLCNMD
| Q4 25 | — | 0.81× | ||
| Q3 25 | — | 0.85× | ||
| Q2 25 | — | 0.88× | ||
| Q1 25 | — | 0.91× | ||
| Q4 24 | — | 0.94× | ||
| Q3 24 | — | 1.01× | ||
| Q2 24 | — | 1.09× | ||
| Q1 24 | — | 1.16× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-10.8M | $46.3M |
| 自由现金流经营现金流 - 资本支出 | $-11.0M | $41.2M |
| 自由现金流率自由现金流/营收 | -44.2% | 11.0% |
| 资本支出强度资本支出/营收 | 0.7% | 1.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-41.6M | $150.9M |
8季度趋势，按日历期对齐
经营现金流CBLLCNMD
| Q4 25 | $-10.8M | $46.3M | ||
| Q3 25 | $-11.1M | $53.7M | ||
| Q2 25 | $-7.5M | $29.1M | ||
| Q1 25 | $-11.4M | $41.5M | ||
| Q4 24 | — | $43.3M | ||
| Q3 24 | — | $51.2M | ||
| Q2 24 | — | $43.3M | ||
| Q1 24 | — | $29.1M |
自由现金流CBLLCNMD
| Q4 25 | $-11.0M | $41.2M | ||
| Q3 25 | $-11.5M | $48.5M | ||
| Q2 25 | $-7.6M | $23.4M | ||
| Q1 25 | $-11.6M | $37.8M | ||
| Q4 24 | — | $39.3M | ||
| Q3 24 | — | $47.8M | ||
| Q2 24 | — | $39.7M | ||
| Q1 24 | — | $27.1M |
自由现金流率CBLLCNMD
| Q4 25 | -44.2% | 11.0% | ||
| Q3 25 | -50.8% | 14.4% | ||
| Q2 25 | -35.9% | 6.8% | ||
| Q1 25 | -56.4% | 11.8% | ||
| Q4 24 | — | 11.4% | ||
| Q3 24 | — | 15.1% | ||
| Q2 24 | — | 12.0% | ||
| Q1 24 | — | 8.7% |
资本支出强度CBLLCNMD
| Q4 25 | 0.7% | 1.4% | ||
| Q3 25 | 1.6% | 1.5% | ||
| Q2 25 | 0.3% | 1.7% | ||
| Q1 25 | 0.7% | 1.2% | ||
| Q4 24 | — | 1.2% | ||
| Q3 24 | — | 1.1% | ||
| Q2 24 | — | 1.1% | ||
| Q1 24 | — | 0.7% |
现金转化率CBLLCNMD
| Q4 25 | — | — | ||
| Q3 25 | — | 18.78× | ||
| Q2 25 | — | 1.36× | ||
| Q1 25 | — | 6.88× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.05× | ||
| Q2 24 | — | 1.44× | ||
| Q1 24 | — | 1.48× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CBLL
| Products | $18.8M | 76% |
| Subscription | $6.0M | 24% |
CNMD
| Transferred At Point In Time | $358.5M | 96% |
| Transferred Over Time | $14.7M | 4% |
